VAERS reports by lot

Pfizer COVID-19 lot EWO164: VAERS reports

36 VAERS reports list lot EWO164 as a Pfizer COVID-19 vaccine, received between 2021-04-17 and 2022-03-28. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
36
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5227%
Neurological3417%
Dermatological (non-injection-site)2111%
Cardiac / Cardiovascular189%
Gastrointestinal179%
Musculoskeletal168%
Injection-site / Local reaction116%
Allergic / Anaphylactic105%
Respiratory74%
Thrombotic / Hematological42%
Psychiatric / Neuropsychiatric42%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Indiana9
Florida5
New York3
Michigan3
California3
Wisconsin2
Illinois2
Oregon1
Colorado1
Washington1
Kentucky1
Oklahoma1

Reports by month received

MonthReportsBar
2021-0414
2021-058
2021-064
2021-071
2021-082
2021-092
2021-104
2022-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Pfizer COVID-19 lots (A–Z): EWO158 · EWO161 · EWO162 · EWO167 · EWO168 · EWO169

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.